ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $49,177 | +18.2% | 847 | +9.6% | 0.00% | +50.0% |
Q2 2023 | $41,611 | +35.5% | 773 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $30,704 | -1.3% | 773 | 0.0% | 0.00% | +100.0% |
Q4 2022 | $31,098 | +25.2% | 773 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $24,844 | +8.3% | 773 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $22,935 | +5.6% | 773 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $21,729 | -83.7% | 773 | -73.3% | 0.00% | -50.0% |
Q4 2021 | $133,632 | +40.4% | 2,900 | 0.0% | 0.00% | +100.0% |
Q3 2021 | $95,178 | +19.5% | 2,900 | +5.7% | 0.00% | 0.0% |
Q4 2020 | $79,657 | +2.9% | 2,743 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $77,380 | -12.8% | 2,743 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $88,709 | -20.6% | 2,743 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $111,750 | -49.0% | 2,743 | -22.8% | 0.00% | -50.0% |
Q4 2019 | $219,114 | -15.4% | 3,553 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $258,943 | +9.7% | 3,553 | +23.7% | 0.00% | 0.0% |
Q2 2019 | $236,078 | +16.5% | 2,872 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $202,591 | +56.7% | 2,872 | 0.0% | 0.00% | +33.3% |
Q4 2018 | $129,297 | -20.4% | 2,872 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $162,383 | -99.9% | 2,872 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $191,850,000 | +14.7% | 2,872 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $167,208,000 | +90282.7% | 2,872 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $185,000 | -39.1% | 2,872 | -50.3% | 0.00% | 0.0% |
Q3 2017 | $304,000 | +12.2% | 5,784 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $271,000 | -5.2% | 5,784 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $286,000 | -18.5% | 5,784 | 0.0% | 0.00% | -33.3% |
Q4 2016 | $351,000 | -8.6% | 5,784 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $384,000 | +9.7% | 5,784 | -7.8% | 0.00% | 0.0% |
Q2 2016 | $350,000 | +37.3% | 6,274 | -17.2% | 0.00% | +50.0% |
Q1 2016 | $255,000 | +9.4% | 7,579 | +46.6% | 0.00% | 0.0% |
Q4 2015 | $233,000 | +14.2% | 5,169 | 0.0% | 0.00% | +100.0% |
Q3 2015 | $204,000 | -41.5% | 5,169 | -8.2% | 0.00% | -50.0% |
Q2 2015 | $349,000 | +5.1% | 5,628 | +6.0% | 0.00% | 0.0% |
Q1 2015 | $332,000 | +11.0% | 5,309 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $299,000 | +33.5% | 5,309 | -32.9% | 0.00% | 0.0% |
Q3 2014 | $224,000 | -17.6% | 7,908 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $272,000 | – | 7,908 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |